Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-100.21%
operating margin TTM
-872.68%
revenue TTM
288.33 Thousand
revenue per share TTM
0.07$
valuation ratios | |
|---|---|
| pe ratio | -10.05 |
| peg ratio | 0.00 |
| price to book ratio | 0.65 |
| price to sales ratio | 10.08 |
| enterprise value multiple | -2.99 |
| price fair value | 0.65 |
profitability ratios | |
|---|---|
| gross profit margin | 75.14% |
| operating profit margin | -872.68% |
| pretax profit margin | -172.7% |
| net profit margin | -100.21% |
| return on assets | -2.89% |
| return on equity | -6.02% |
| return on capital employed | -35.82% |
liquidity ratios | |
|---|---|
| current ratio | 1.95 |
| quick ratio | 1.78 |
| cash ratio | 0.27 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 2,669.93 |
| operating cycle | 2,810.84 |
| days of payables outstanding | 4,341.75 |
| cash conversion cycle | -1,530.91 |
| receivables turnover | 2.59 |
| payables turnover | 0.08 |
| inventory turnover | 0.14 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.25 |
| debt equity ratio | 0.56 |
| long term debt to capitalization | 0.20 |
| total debt to capitalization | 0.36 |
| interest coverage | -8.04 |
| cash flow to debt ratio | -0.80 |
cash flow ratios | |
|---|---|
| free cash flow per share | -1.87 |
| cash per share | 4.80 |
| operating cash flow per share | -1.86 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | -0.80 |
| short term coverage ratios | -1.72 |
| capital expenditure coverage ratio | -321.59 |
Frequently Asked Questions
When was the last time BioLineRx Ltd. (NASDAQ:BLRX) reported earnings?
BioLineRx Ltd. (BLRX) published its most recent earnings results on 24-11-2025.
What is BioLineRx Ltd.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. BioLineRx Ltd. (NASDAQ:BLRX)'s trailing twelve months ROE is -6.02%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. BioLineRx Ltd. (BLRX) currently has a ROA of -2.89%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did BLRX's net profit margin stand at?
BLRX reported a profit margin of -100.21% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is BLRX's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 1.95 in the most recent quarter. The quick ratio stood at 1.78, with a Debt/Eq ratio of 0.56.